Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer?

REFERENCES

• Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG, Ladogana A, Pocchiari M, Leschek EW, Schonberger LB. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 2012; 18:901-7; PMID:22607808; http://dx.doi.org/10.3201/eid1806.120116
   PubMed Web of Science ®Google Scholar
• Kovacs GG. molecular pathological classification of neurodegenerative diseases: turning towards precision medicine. Int J Mol Sci 2016; 17:189; http://dx.doi.org/10.3390/ijms17020189
   Web of Science ®Google Scholar
• Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013; 501:45-51; PMID:24005412; http://dx.doi.org/10.1038/nature12481
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Del Tredici K, Lee VM, Trojanowski JQ. Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 2015; 16:109-20; PMID:25588378; http://dx.doi.org/10.1038/nrn3887
   PubMed Web of Science ®Google Scholar
• Fraser H. Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway. Nature 1982; 295:149-50; PMID:6173756; http://dx.doi.org/10.1038/295149a0
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Rahimi J, Strobel T, Lutz MI, Regelsberger G, Streichenberger N, Perret-Liaudet A, Hoftberger R, Liberski PP, Budka H, et al. Tau pathology in Creutzfeldt-Jakob disease revisited. Brain Pathol 2016; PMID:27377321
   PubMedGoogle Scholar
• Tousseyn T, Bajsarowicz K, Sanchez H, Gheyara A, Oehler A, Geschwind M, DeArmond B, DeArmond SJ. Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes. J Neuropathol Exp Neurol 2015; 74:873-88; PMID:26226132; http://dx.doi.org/10.1097/NEN.0000000000000228
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Seguin J, Quadrio I, Hoftberger R, Kapas I, Streichenberger N, Biacabe AG, Meyronet D, Sciot R, Vandenberghe R, et al. Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol 2011; 121:39-57; PMID:20593190; http://dx.doi.org/10.1007/s00401-010-0713-y
   PubMed Web of Science ®Google Scholar
• Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 2009; 118:5-36; PMID:19381658; http://dx.doi.org/10.1007/s00401-009-0532-1
   PubMed Web of Science ®Google Scholar
• Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012; 123:1-11; PMID:22101365; http://dx.doi.org/10.1007/s00401-011-0910-3
   PubMed Web of Science ®Google Scholar
• Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011; 70:960-9; PMID:22002422; http://dx.doi.org/10.1097/NEN.0b013e318232a379
   PubMed Web of Science ®Google Scholar
• Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement 2016; 12:292-323; PMID:27012484; http://dx.doi.org/10.1016/j.jalz.2016.02.002
   PubMed Web of Science ®Google Scholar
• Pletnikova O, Rudow GL, Hyde TM, Kleinman JE, Ali SZ, Bharadwaj R, Gangadeen S, Crain BJ, Fowler DR, Rubio AI, et al. Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age. Cogn Behav Neurol 2015; 28:144-52; PMID:26413742; http://dx.doi.org/10.1097/WNN.0000000000000071
   PubMed Web of Science ®Google Scholar
• Cacace R, Sleegers K, Van Broeckhoven C. Molecular genetics of early-onset Alzheimer's disease revisited. Alzheimers Dement 2016; 12:733-48; PMID:27016693; http://dx.doi.org/10.1016/j.jalz.2016.01.012
   PubMed Web of Science ®Google Scholar
• Thal DR, Griffin WS, de Vos RA, Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 2008; 115:599-609; PMID:18369648; http://dx.doi.org/10.1007/s00401-008-0366-2
   PubMed Web of Science ®Google Scholar
• Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 1989; 477:90-9; PMID:2495152; http://dx.doi.org/10.1016/0006-8993(89)91396-6
   PubMed Web of Science ®Google Scholar
• Eisele YS, Duyckaerts C. Propagation of Abeta pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 2016; 131:5-25; PMID:26715565; http://dx.doi.org/10.1007/s00401-015-1516-y
   PubMed Web of Science ®Google Scholar
• Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H. The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowledge Environ 2006; 2006:re1; PMID:16525193; http://dx.doi.org/10.1126/sageke.2006.6.re1
   PubMedGoogle Scholar
• Wang D, Munoz DG. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. J Neuropathol Exp Neurol 1995; 54:548-56; PMID:7602328; http://dx.doi.org/10.1097/00005072-199507000-00009
   PubMed Web of Science ®Google Scholar
• Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997; 56:321-39; PMID:9100663; http://dx.doi.org/10.1097/00005072-199704000-00001
   PubMed Web of Science ®Google Scholar
• Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112:389-404; PMID:16906426; http://dx.doi.org/10.1007/s00401-006-0127-z
   PubMed Web of Science ®Google Scholar
• Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58:1791-800; PMID:12084879; http://dx.doi.org/10.1212/WNL.58.12.1791
   PubMed Web of Science ®Google Scholar
• Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S. Tau, prions and Abeta: the triad of neurodegeneration. Acta Neuropathol 2011; 121:5-20; PMID:20473510; http://dx.doi.org/10.1007/s00401-010-0691-0
   PubMed Web of Science ®Google Scholar
• Ghoshal N, Cali I, Perrin RJ, Josephson SA, Sun N, Gambetti P, Morris JC. Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype. Arch Neurol 2009; 66:1240-6; PMID:19822779; http://dx.doi.org/10.1001/archneurol.2009.224
   PubMedGoogle Scholar
• Jaunmuktane Z, Mead S, Ellis M, Wadsworth JD, Nicoll AJ, Kenny J, Launchbury F, Linehan J, Richard-Loendt A, Walker AS, et al. Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy. Nature 2015; 525:247-50; PMID:26354483; http://dx.doi.org/10.1038/nature15369
   PubMed Web of Science ®Google Scholar
• Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ. Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 2013; 70:462-8; PMID:23380910; http://dx.doi.org/10.1001/jamaneurol.2013.1933
   PubMed Web of Science ®Google Scholar
• Frontzek K, Lutz MI, Aguzzi A, Kovacs GG, Budka H. Amyloid-beta pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. Swiss Med Wkly 2016; 146:w14287; PMID:26812492
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Lutz MI, Ricken G, Strobel T, Hoftberger R, Preusser M, Regelsberger G, Honigschnabl S, Reiner A, Fischer P, et al. Dura mater is a potential source of Abeta seeds. Acta Neuropathol 2016; 131:911-23; PMID:27016065; http://dx.doi.org/10.1007/s00401-016-1565-x
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S, Iwasaki Y, Yoshida M, Shimizu H, Kakita A, et al. Significant association of cadaveric dura mater grafting with subpial Abeta deposition and meningeal amyloid angiopathy. Acta Neuropathol 2016; 132:313-5; PMID:27314593; http://dx.doi.org/10.1007/s00401-016-1588-3
   PubMed Web of Science ®Google Scholar
• Morales R, Callegari K, Soto C. Prion-like features of misfolded Abeta and tau aggregates. Virus Res 2015; 207:106-12; PMID:25575736; http://dx.doi.org/10.1016/j.virusres.2014.12.031
   PubMed Web of Science ®Google Scholar
• Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001; 293:1491-5; PMID:11520988; http://dx.doi.org/10.1126/science.1062097
   PubMed Web of Science ®Google Scholar
• Edgren G, Hjalgrim H, Rostgaard K, Lambert P, Wikman A, Norda R, Titlestad KE, Erikstrup C, Ullum H, Melbye M, et al. Transmission of Neurodegenerative Disorders Through Blood Transfusion: A Cohort Study. Ann Intern Med 2016; 165:316–324
   Web of Science ®Google Scholar